domperidone has been researched along with Infections, Staphylococcal in 2 studies
Domperidone: A specific blocker of dopamine receptors. It speeds gastrointestinal peristalsis, causes prolactin release, and is used as antiemetic and tool in the study of dopaminergic mechanisms.
domperidone : 1-[3-(Piperidin-1-yl)propyl]-1,3-dihydro-2H-benzimidazol-2-one in which the 4-position of the piperidine ring is substituted by a 5-chloro-1,3-dihydro-2H-benzimidazol-2-on-1-yl group. A dopamine antagonist, it is used as an antiemetic for the short-term treatment of nausea and vomiting, and to control gastrointestinal effects of dopaminergic drugs given in the management of parkinsonism. The free base is used in oral suspensions, while the maleate salt is used in tablet preparations.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
El-Ganiny, AM | 1 |
Gad, AI | 1 |
El-Sayed, MA | 2 |
Shaldam, MA | 1 |
Abbas, HA | 1 |
Abdel-Karim, SAM | 1 |
El-Ganiny, AMA | 1 |
Abbas, HAA | 1 |
2 other studies available for domperidone and Infections, Staphylococcal
Article | Year |
---|---|
The promising anti-virulence activity of candesartan, domperidone, and miconazole on Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Benzimidazoles; Biofilms; Biphenyl Compounds; Domperidone; Humans; Methicilli | 2022 |
Promising FDA-approved drugs with efflux pump inhibitory activities against clinical isolates of Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Diclofenac; Domperidone; Humans; Metformin; Microbial Sen | 2022 |